Leanox
Leanox, licence 80094861: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- NOVA PHARMA
- Licence holder
- Nova-Pharma
- NPN or DIN-HM
- 80094861
- Status
- Active licence
- Licence date
- 11 October 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait de fève de café vert Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 2.0:1.0 Dry plant equivalent : 400.0 mg Potency : 4.0 % Caffeine | 200.0 mg | Not calculated |
| Extrait de fève de café vert Source : Graine(s) Potency : 50.0 % Chlorogenic acids | Not specified | Not calculated |
| Acide linoléique conjugué Source : Acide linoléique conjugué | 180.0 mg | Not calculated |
| Irvingia gabonensis Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 750.0 mg Potency : 7.0 % Albumin | 75.0 mg | Not calculated |
| L-Carnitine Source : L-tartrate de carnitine | 750.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support fat metabolism. Helps to promote healthy glucose metabolism. Provides antioxidants. Helps to maintain the body¿s ability to metabolize nutrients. Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals involved in a weight management program. Aids in the muscle recovery process by reducing muscle tissue damage associated with a resistance training regimen. Helps support muscle tissue repair in individuals involved in resistance training. Workout support/supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80094861
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.